Compare Monolithic Power Systems Inc (MPWR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monolithic Power Systems Inc vs BIO-TECHNE Corp — how do they compare? Monolithic Power Systems Inc trades at $1,197.69 (market cap $59.88B), while BIO-TECHNE Corp trades at $72.39 (market cap $11.34B). The key difference: Monolithic Power Systems Inc is far larger — about 5.3× BIO-TECHNE Corp's market cap, and Monolithic Power Systems Inc pays the higher dividend (0.66%). Which is the better fit depends on your goals.
| MPWR | TECH | |
|---|---|---|
Market Cap | $59.88B | $11.34B |
Sector | Utilities | Health |
52-Week High | $1.69K | $72.48 |
52-Week Low | $834.14 | $43.31 |
Enterprise Value | $58.49B | $11.36B |
Dividend Yield | 0.66% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPWR trades at $1,218.50, down 0.44% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The company reported strong Q2 2026 results with EPS of $6.50 beating expectations of $5.87, driven by AI infrastructure demand. Valuation remains elevated with a P/E of 74.34 and P/S of 18.21, while profitability metrics show robust net income margin of 24.5% and ROE of 21.98%.
The stock faces near-term technical pressure but maintains strong fundamental growth prospects from AI and server demand. Analyst consensus remains overwhelmingly bullish with 88% buy ratings and a $1,860 price target representing 53% upside. Key risks include premium valuation concerns and potential double-ordering in enterprise data segments.
Bio-Techne (TECH) trades at $72.31, down 0.17% on the day, with a neutral technical signal and mixed earnings history. The stock is near the consensus price target of $71.86, with a pending acquisition by Merck KGaA at $73.00 per share. Recent Q4 2026 revenue beat estimates, but net income margin compression from 25.09% in 2023 to 14.96% in 2026 highlights profitability challenges. Operating cash flow remains stable around $290M, supporting dividend payments.
The outlook is balanced, with upside capped by the acquisition offer but supported by solid cash flow and analyst hold ratings. Risks include shareholder litigation and integration uncertainties post-acquisition. Earnings growth in diagnostics and spatial biology segments is a key catalyst, though high P/E of 62.33 suggests elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
